Go Pro

HC Wainwright's Rating of Portage Biotech on 2/24/2026

On February 24, 2026, HC Wainwright updated its outlook on Portage Biotech (NASDAQ:ATON) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
7/16/2026
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
Reiterated Rating
7/16/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Reiterated Rating
7/16/2026
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
Reiterated Rating
7/16/2026
Uranium Royalty Corp. stock logo
UROY
Uranium Royalty
Reiterated Rating
7/16/2026
Dakota Gold Corp. stock logo
DC
Dakota Gold
Boost Price Target
7/16/2026
DRDGOLD Limited stock logo
DRD
DRDGOLD
Reiterated Rating
More Ratings From HC Wainwright